UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Reduced by Huntington National Bank

Huntington National Bank lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 125,283 shares of the healthcare conglomerate's stock after selling 3,151 shares during the quarter. Huntington National Bank's holdings in UnitedHealth Group were worth $63,375,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Howard Capital Management Group LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $341,000. Principal Financial Group Inc. raised its stake in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. Bamco Inc. NY boosted its position in UnitedHealth Group by 2.0% in the third quarter. Bamco Inc. NY now owns 56,890 shares of the healthcare conglomerate's stock valued at $33,262,000 after buying an additional 1,089 shares during the last quarter. Concentric Capital Strategies LP lifted its stake in UnitedHealth Group by 40.2% during the 3rd quarter. Concentric Capital Strategies LP now owns 3,843 shares of the healthcare conglomerate's stock valued at $2,247,000 after acquiring an additional 1,101 shares during the period. Finally, Cinctive Capital Management LP acquired a new stake in shares of UnitedHealth Group in the third quarter worth $3,619,000. 87.86% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on UNH shares. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Barclays lowered their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Finally, Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Up 0.1 %

Shares of UNH traded up $0.49 during midday trading on Wednesday, hitting $523.61. The company had a trading volume of 2,368,702 shares, compared to its average volume of 4,235,187. The stock has a market cap of $478.95 billion, a price-to-earnings ratio of 33.78, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company's 50 day moving average price is $509.15 and its 200 day moving average price is $542.83. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.